Ceperognastat Shows Promise in Early Symptomatic Alzheimer’s Disease Treatment
A recent study published in JAMA has tested the efficacy of Ceperognastat, an innovative oral small-molecule inhibitor targeting O-linked N-acetylglucosaminidase ...
Tag: Alzheimer’s disease drug development
Promising New Drug Shows Potential to Slow Alzheimer’s Progression
In a groundbreaking advancement in Alzheimer’s disease research, a team led by Professor Ursula Quitterer at ETH Zurich has developed ...
Novel ALS Drug Demonstrates Promising Efficacy Against Alzheimer’s Disease in Recent Animal Study
Northwestern University's latest groundbreaking research unveils the potential of NU-9, an experimental small molecule compound approved for clinical trials targeted ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!